Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.

Ouimet T, Orng SV, Poras H, Gagnidze K, Devi LA, Fournié-Zaluski MC, Roques BP.

J Biol Chem. 2010 Nov 5;285(45):34390-400. doi: 10.1074/jbc.M110.120576. Epub 2010 Aug 31.

2.
3.
4.

Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors.

Luciani N, de Rocquigny H, Turcaud S, Romieu A, Roques BP.

Biochem J. 2001 Jun 15;356(Pt 3):813-9.

5.
6.

Molecular pharmacology of endothelin converting enzymes.

Turner AJ, Murphy LJ.

Biochem Pharmacol. 1996 Jan 26;51(2):91-102. Review.

PMID:
8615890
7.

Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations.

Schweizer A, Valdenaire O, Nelböck P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Löffler BM.

Biochem J. 1997 Dec 15;328 ( Pt 3):871-7.

8.

Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.

Ahn K, Herman SB, Fahnoe DC.

Arch Biochem Biophys. 1998 Nov 15;359(2):258-68.

PMID:
9808768
9.

Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain.

Meidan R, Klipper E, Gilboa T, Muller L, Levy N.

J Biol Chem. 2005 Dec 9;280(49):40867-74. Epub 2005 Sep 26.

10.

Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin.

Johnson GD, Stevenson T, Ahn K.

J Biol Chem. 1999 Feb 12;274(7):4053-8.

11.

New short peptide substrates of endothelin-converting enzyme and characterization of the enzyme.

Létourneau M, Roby P, Tremblay F, Carette J, Fournier A.

J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S28-9.

PMID:
11078327
12.

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.

Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M.

Cell. 1994 Aug 12;78(3):473-85.

PMID:
8062389
13.

Lactoferricin B-derived peptides with inhibitory effects on ECE-dependent vasoconstriction.

Fernández-Musoles R, López-Díez JJ, Torregrosa G, Vallés S, Alborch E, Manzanares P, Salom JB.

Peptides. 2010 Oct;31(10):1926-33. doi: 10.1016/j.peptides.2010.06.024. Epub 2010 Jun 30.

PMID:
20600419
14.

Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.

Deprez-Roy I, Coge F, Bertry L, Galizzi JP, Feletou M, Vanhoutte PM, Canet E.

Acta Pharmacol Sin. 2000 Jun;21(6):499-506.

15.

Big endothelin analogues with inhibitory activity on endothelin-converting enzyme-1.

Takayanagi R, Liu W, Ito T, Ohnaka K, Nawata H.

J Cardiovasc Pharmacol. 1998;31 Suppl 1:S62-3.

PMID:
9595401
16.
17.

Identification of endothelin converting enzyme-1 in human non-pigmented ciliary epithelial cells.

Prasanna G, Dibas A, Finkley A, Yorio T.

Exp Eye Res. 1999 Aug;69(2):175-83.

PMID:
10433854
18.
19.

A fluorogenic assay for endothelin-converting enzyme.

von Geldern TW, Holleman WH, Opgenorth TJ.

Pept Res. 1991 Jan-Feb;4(1):32-5.

PMID:
1802235
20.

Physiologic shear stress suppresses endothelin-converting enzyme-1 expression in vascular endothelial cells.

Masatsugu K, Itoh H, Chun TH, Ogawa Y, Tamura N, Yamashita J, Doi K, Inoue M, Fukunaga Y, Sawada N, Saito T, Korenaga R, Ando J, Nakao K.

J Cardiovasc Pharmacol. 1998;31 Suppl 1:S42-5.

PMID:
9595395

Supplemental Content

Support Center